Previous 10 | Next 10 |
Gainers: Alpine Immune Sciences (NASDAQ: ALPN ) +174% . More news on: Alpine Immune Sciences, Inc., Aethlon Medical, Inc., Urban One, Inc., Stocks on the move, , Read more ...
Francesca's Holdings (NASDAQ: FRAN ) -24% on Q1 results . More news on: Francesca's Holdings Corporation, Medley Management Inc., Brickell Biotech, Inc., Stocks on the move, , Read more ...
Brickell Biotech (NASDAQ: BBI ) has priced its public offering of 17.5M common shares, or pre-funded warrants to purchase common shares in-lieu of common stock and investor warrants to purchase up to same number common shares of common stock. More news on: Brickell Biotech, Inc...
BOULDER, Colo., June 17, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today ann...
Gainers: Cohen & Company (NYSEMKT: COHN ) +128% . More news on: Cohen & Company Inc., LM Funding America, Inc., Integrated Media Technology Limited, Stocks on the move, , Read more ...
Urban One (NASDAQ: UONE ) -24% . More news on: Urban One, Inc., The9 Limited, China HGS Real Estate Inc., Stocks on the move, , Read more ...
Gainers: Urban One (NASDAQ: UONE ) +167% . More news on: Urban One, Inc., Edesa Biotech, Inc., Net Element, Inc., Stocks on the move, , Read more ...
Edesa Biotech (NASDAQ: EDSA ) +218% on launch of COVID-19 study in Canada. More news on: Edesa Biotech, Inc., Brickell Biotech, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
Are These Penny Stocks To Buy Or Avoid This Week? When it comes to penny stocks , things can change at a moment’s notice. We saw this first-hand over the last few days. On Friday, there were several stocks under $5 that finished the week strong. But if you were to look at them on Monda...
Thinly traded nano cap Brickell Biotech (NASDAQ: BBI ) is up 118% premarket on increased volume in reaction to positive data from a Japan-based Phase 3 clinical trial evaluating lead candidate topical sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosis ...
News, Short Squeeze, Breakout and More Instantly...
Brickell Biotech Inc. Company Name:
BBI Stock Symbol:
NYSE Market:
New name, logo, website, and branding reflect the Company’s strategic shift toward developing potentially groundbreaking autoimmune and inflammatory disease therapies Company to begin trading under new ticker symbol “FRTX” on September 8, 2022 Compan...
Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month On track to report SAD and MAD topline results from BBI-02 Phase 1 study by early 2023 Development of BBI-10 and next-generation kinase inhibitors advancing through early precl...
BOULDER, Colo., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoi...